IRIS
RICCARDI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.011
AS - Asia 3.919
EU - Europa 3.756
SA - Sud America 348
AF - Africa 40
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.925
CN - Cina 2.448
SG - Singapore 805
UA - Ucraina 805
IE - Irlanda 748
FI - Finlandia 482
DE - Germania 450
HK - Hong Kong 385
SE - Svezia 361
BR - Brasile 300
RU - Federazione Russa 290
IT - Italia 219
GB - Regno Unito 209
VN - Vietnam 82
FR - Francia 81
CA - Canada 60
IN - India 47
AU - Australia 24
JP - Giappone 20
AR - Argentina 19
BD - Bangladesh 19
BE - Belgio 19
MX - Messico 18
PL - Polonia 18
CZ - Repubblica Ceca 17
TR - Turchia 17
ZA - Sudafrica 16
KR - Corea 15
IQ - Iraq 12
NL - Olanda 12
MY - Malesia 10
ID - Indonesia 9
CL - Cile 8
EG - Egitto 7
ES - Italia 7
IR - Iran 7
JO - Giordania 6
MA - Marocco 6
NZ - Nuova Zelanda 6
VE - Venezuela 6
EC - Ecuador 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
GR - Grecia 4
TH - Thailandia 4
TW - Taiwan 4
UZ - Uzbekistan 4
BY - Bielorussia 3
CH - Svizzera 3
CO - Colombia 3
DZ - Algeria 3
IL - Israele 3
LT - Lituania 3
PK - Pakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
BG - Bulgaria 2
CR - Costa Rica 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MU - Mauritius 2
NG - Nigeria 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BB - Barbados 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 13.105
Salva come PNG Salva come JPEG
Città #
Chandler 889
Jacksonville 861
Dublin 747
Nanjing 615
Hong Kong 375
Singapore 348
Ashburn 337
Beijing 313
Boardman 284
Dallas 254
Nanchang 246
Princeton 197
Lawrence 174
Changsha 172
Shenyang 171
Hebei 158
Wilmington 136
Helsinki 135
Medford 127
Los Angeles 113
Jiaxing 111
Tianjin 109
Hangzhou 96
Milan 78
Ann Arbor 74
Buffalo 67
Redondo Beach 62
Munich 46
Verona 44
Houston 42
Moscow 41
Shanghai 38
Woodbridge 37
New York 36
Ho Chi Minh City 31
Norwalk 30
Toronto 30
Kunming 28
São Paulo 27
Seattle 22
Guangzhou 21
San Francisco 21
Brussels 19
Chicago 19
Jinan 19
Brooklyn 17
Hanoi 17
Warsaw 17
Chennai 15
Falkenstein 14
Tokyo 14
Pavia 13
Zhengzhou 13
Montreal 12
Rio de Janeiro 12
Turku 12
Atlanta 11
Auburn Hills 11
Boston 11
Des Moines 11
Fairfield 11
Johannesburg 11
San Genesio Ed Uniti 11
Melbourne 10
Stockholm 10
Belo Horizonte 9
Mexico City 9
Brno 8
Campinas 8
Falls Church 8
Manchester 8
Ningbo 8
Prague 8
George Town 7
Haikou 7
Lanzhou 7
Santa Clara 7
Secaucus 7
Sydney 7
Changchun 6
Denver 6
London 6
Orem 6
Phoenix 6
Poplar 6
Taizhou 6
Amman 5
Brasília 5
Charlotte 5
Cleveland 5
Council Bluffs 5
Dhaka 5
New Delhi 5
Nuremberg 5
Paris 5
Suwon 5
Tappahannock 5
Washington 5
Al Fayyum 4
Amsterdam 4
Totale 8.271
Salva come PNG Salva come JPEG
Nome #
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. 218
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 132
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 121
Cell kinetic characterization of human brain tumors 111
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study 111
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01). 110
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients 108
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 106
Use of bisphosphonates in oncology: physiopathologic bases and clinical activity. 104
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 104
A study of biological behaviour of human brain tumors. Part I. Arachidonic acid metabolism and DNA content. 104
Anemie in oncologia. 104
AIDS-associated non-Hodgkin's lymphomas in Italy: intravenous drug abusers versus homosexual men 102
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 102
A prospective comparison of a-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 102
- GM-CSF increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications and bone marrow kinetics. 99
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. 98
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 97
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. 97
Anemie megaloblastiche. 97
- Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational controlled trial. 96
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 96
Anemie megaloblastiche. 96
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 95
G2 synchronization in human acute leukemia after VP 16 213 therapy. 95
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 95
A rapid cytofluorometric method for quantitative DNA determination on fixed smears. 93
VEGF-induced intracellular Ca2+oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells 93
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy. 92
A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera. 92
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells. 90
A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. 90
Linee guida per la diagnosi, il trattamento e la riabilitazione del carcinoma polmonare 89
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues. 89
The PAS reactivity of lymph-node blast cells in non-Hodgkin's malignant lymphomas. 87
P-glycoprotein expression in multiple myeloma. 87
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 87
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 86
Biologia e clinica del mieloma multiplo. 86
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 86
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. V. Effect of VP 16 213 studied with flow cytofluorometry and cytoautoradiography. 85
Strategies of medical treatment for metastatic breast cancer 85
Cytokinetic studies in two cases of plasma cell leukemia. 84
Ploidy and proliferative activity in uterine tumors: an in vivo study using bromodeoxyuridine and flow cytometry. 83
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 83
I linfomi non Hodgkin (linfosarcomi, reticolosarcomi). 83
In vitro killing of colorectal carcinoma cells by autologous activated NK cells is boosted by anti-epidermal growth factor receptor-induced ADCC regardless of RAS mutation status 83
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 82
Changing clinical presentation of multiple myeloma. 82
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 82
Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. 82
Sequential intrahepatic and systemic fluoropyrimidines-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study. 81
New agents in medical oncology and the risk of venous thromboembolism. 81
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. 81
Intrathecal methotrexate neurotoxicity. 80
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomized study by the Italian Trials in Medical Oncology (ITMO) Group. 80
DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies 79
Double heterozygosity for haemoglobin Malmø [ß97 (FG4) His-Glu] and ß-thalassemia traits, with unusually high haematocrit values, in a Sicilian man. 79
Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer. 79
Applicazioni cliniche dei fattori di crescita emopoietici. 79
Fisiopatologia dell'eritrocito. 79
Cell kinetic studies of human intracranial tumors. 79
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study. 78
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 78
Expression of p53 protein during the cell cycle mesaured by flow cytometry in human leukemia. 78
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 78
Il trattamento medico del carcinoma mammario. 78
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 78
Angiogenesi: esperienze cliniche 77
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer. 77
Studio morfologico e citochimico dei megacariociti in 25 casi di displasie emopoietiche. 76
High-dose chemotherapy (HDT) with tandem autologous peripheral blood cells (PBPC) transplantation for patients with metastatic breast cancer (MBC) 76
La citofluorimetria a flusso nella diagnostica ematologica ed oncologica. 76
Effect of Vincristine on the bone marrow cells of patients with multiple myeloma: a cytomorphologic study. 75
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. 75
Weekly taxanes in metastatic breast cancer. 74
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. 74
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 73
Prerequisites for in vivo cell kinetic studies in patients. 73
Nuove strategie di impiego dei fattori di crescita mielopoietici. 73
Doubling the epirubicin dosage in the 5-fluorouracil, epirubicin and cyclophosphamide (FEC) regimen for advanced breast cancer: a prospective, randomized, multicentric study on antitumor effect and life quality 73
Interferon alpha-2b in the long-term treatment of essential thrombocythemia. 73
Applicazioni cliniche della citometria. 73
Fisiopatologia dell'eritrocito. 73
Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term a-IFN treatment. 73
Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation. 72
Paclitaxel in anthracycline-treated breast cancer patients. 72
Serum Pharmacokinetics in Patients Treated with Transarterial Chemoembolization (TACE) Using Two Types of Epirubicin-loaded Microspheres. 72
Myelodysplastic syndromes: biologic and clinical aspects. 72
Il carcinoma mammario operabile. Linee guida per la diagnosi, il trattamento e la riabilitazione. 72
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients 72
Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non lymphoblastic leukemia. 72
HER-2 / neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma. 71
Interim analysis of the Grocta 8 adjuvant trial in breast cancer patients with ten or more involved nodes 71
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomised protocol. 71
Central indwelling catheter to prevent phlebosclerosis by Peptichemio in patients with multiple myeloma 71
Deoxyribonucleic acid content of cleaved and non-cleaved cells in follicular center cell lymphomas. 71
Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo Study NCT 03822936) 70
The use of peripheral blood haemopoietic progenitors mobilized with standard dose chemotherapy plus G-CSF to support multicyclic dose-intensive chemotherapy for advanced breast cancer. 70
Gemcitabine and oxaliplatin to treat immunotherapy-resistant advanced renal cell carcinoma patients: final results of a single institution phase II study 70
Totale 8.639
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021883 0 0 0 0 0 204 7 169 56 199 193 55
2021/2022810 5 2 21 11 20 32 19 31 41 16 127 485
2022/20232.425 301 127 25 238 317 257 0 134 914 14 53 45
2023/2024718 130 146 25 62 68 167 11 28 8 29 27 17
2024/20251.921 42 208 54 73 41 53 66 181 434 42 192 535
2025/20262.186 351 367 438 434 444 152 0 0 0 0 0 0
Totale 13.166